A temperature-sensitive phase-change hydrogel of tamoxifen achieves the long-acting antitumor activation on breast cancer cells

Background: Breast cancer is one of the foremost threats to female health nowadays. Tamoxifen, an antagonist of estrogen receptor-α (ERα), is the first choice for endocrine-dependent breast cancer (ERα-positive breast cancer) treatment. However, ERα has an important function in the normal physical r...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Du, Lei, Hongwei, Zheng, Xiaoqiang, Han, Yaxuan, Sun, Ronggang, Zhao, Dongli, Liu, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538837/
https://www.ncbi.nlm.nih.gov/pubmed/31213826
http://dx.doi.org/10.2147/OTT.S201421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538837/
https://www.ncbi.nlm.nih.gov/pubmed/31213826
http://dx.doi.org/10.2147/OTT.S201421

Ejemplares similares